Cell-intrinsic ceramides determine T cell function during melanoma progression Journal Article


Authors: Hose, M.; Günther, A.; Naser, E.; Schumacher, F.; Schönberger, T.; Falkenstein, J.; Papadamakis, A.; Kleuser, B.; Becker, K. A.; Gulbins, E.; Haimovitz-Friedman, A.; Buer, J.; Westendorf, A. M.; Hansen, W.
Article Title: Cell-intrinsic ceramides determine T cell function during melanoma progression
Abstract: Acid sphingomyelinase (Asm) and acid ceramidase (Ac) are parts of the sphingolipid metabolism. Asm hydrolyzes sphingomyelin to ceramide, which is further metabolized to sphingosine by Ac. Ceramide generates ceramide-enriched platforms that are involved in receptor clustering within cellular membranes. However, the impact of cell-intrinsic ceramide on T cell function is not well characterized. By using T cell-specific Asm- or Ac-deficient mice, with reduced or elevated ceramide levels in T cells, we identified ceramide to play a crucial role in T cell function in vitro and in vivo. T cell-specific ablation of Asm in Smpd1fl/fl/Cd4cre/+ (Asm/CD4cre) mice resulted in enhanced tumor progression associated with impaired T cell responses, whereas Asah1fl/fl/Cd4cre/+ (Ac/CD4cre) mice showed reduced tumor growth rates and elevated T cell activation compared to the respective controls upon tumor transplantation. Further in vitro analysis revealed that decreased ceramide content supports CD4+ regulatory T cell differentiation and interferes with cytotoxic activity of CD8+ T cells. In contrast, elevated ceramide concentration in CD8+ T cells from Ac/CD4cre mice was associated with enhanced cytotoxic activity. Strikingly, ceramide co-localized with the T cell receptor (TCR) and CD3 in the membrane of stimulated T cells and phosphorylation of TCR signaling molecules was elevated in Ac-deficient T cells. Hence, our results indicate that modulation of ceramide levels, by interfering with the Asm or Ac activity has an effect on T cell differentiation and function and might therefore represent a novel therapeutic strategy for the treatment of T cell-dependent diseases such as tumorigenesis. © 2022, Hose, Günther et al.
Keywords: t cells; cd8+ t lymphocyte; cd8-positive t-lymphocytes; mouse; animal; metabolism; animals; mice; melanoma; inflammation; immunology; receptors, antigen, t-cell; sphingolipids; sphingosine; lymphocyte antigen receptor; ceramide; ceramides
Journal Title: eLife
Volume: 11
ISSN: 2050-084X
Publisher: eLife Sciences Publications Ltd.  
Date Published: 2022-11-25
Start Page: e83073
Language: English
DOI: 10.7554/eLife.83073
PUBMED: 36426850
PROVIDER: scopus
PMCID: PMC9699697
DOI/URL:
Notes: Article -- Export Date: 3 January 2023 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors